Your Messages Inbox
Your Article Summary
See Latest ArticlesConvergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment
Trends in Biotechnology , 05/20/09
Phan JH et al. - The authors discuss advanced biocomputing tools for cancer biomarker discovery and multiplexed nanoparticle probes for cancer biomarker profiling, in addition to the prospects for and challenges involved in correlating biomolecular signatures with clinical outcome. This bio-nano-info convergence holds great promise for molecular diagnosis and individualized therapy of cancer and other human diseases.
Related Articles
Obesity linked to specific cancers
Internet Source, 11/05/09
Relevance Score: 97%
Screening for Cancer
MedLinePlus, 11/02/09
Relevance Score: 97%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 97%
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 97%
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 97%
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09
Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09
Article Search
Sponsor